Layer, Julian P.
Hamed, Motaz
Potthoff, Anna-Laura
Dejonckheere, Cas S.
Layer, Katharina
Sarria, Gustavo R.
Scafa, Davide
Koch, David
Köksal, Mümtaz
Kugel, Fabian
Grimmer, Molina
Holz, Jasmin A.
Zeyen, Thomas
Friker, Lea L.
Borger, Valeri
Schmeel, F. Carsten
Weller, Johannes
Hölzel, Michael
Schäfer, Niklas
Garbe, Stephan
Forstbauer, Helmut
Giordano, Frank A.
Herrlinger, Ulrich
Vatter, Hartmut
Schneider, Matthias
Schmeel, L. Christopher
Funding for this research was provided by:
Universitätsklinikum Bonn
Article History
Received: 6 April 2023
Accepted: 20 June 2023
First Online: 21 July 2023
Declarations
:
: J.P.L reports stocks and travel expenses from TME/NOXXON Pharma AG; stocks and honoraria from Siemens Healthineers and stocks from Bayer AG and BioNTech AG. F.A.G. reports research grants and travel expenses from ELEKTA AB and Varian Medical Systems Inc.; grants, stocks, travel expenses and honoraria from TME/NOXXON Pharma AG; research grants, travel expenses and honoraria from Carl Zeiss Meditec AG; travel expenses and honoraria from Bristol-Myers Squibb, Cureteq AG, Guerbet SA, Roche Pharma AG, MSD Sharp and Dohme GmbH and AstraZeneca GmbH; non-financial support from Oncare GmbH and Opasca GmbH. G.R.S. reports personal fees and travel expenses from Carl Zeiss Meditec AG, personal fees from Roche Pharma AG, personal fees from MedWave Clinical Trials and travel expenses from Guerbet SA, not related to this work. U. H. reports advisory Board and/or lecture honoraria from Bayer AG and Medac GmbH.
: The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of the University Hospital Bonn (Approval Number: 018/21 and 057/22). Informed consent was obtained from all patients.